Novacyt: changes to the Board of Directors
In addition, Chief Scientific Officer Joanne Mason will join Novacyt's Board of Directors as a Director as of May 1, while non-executive Director Andrew Health will retire from the Board.
In addition, Novacyt indicates that the publication of its annual results for 2023, initially scheduled for April 30, will take place by the end of May 2024, due to the delay in integrating Yourgene Health into its consolidated results.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction